Jason Hoitt - Net Worth and Insider Trading
Jason Hoitt Net Worth
The estimated net worth of Jason Hoitt is at least $279,559 dollars as of 2024-05-07. Jason Hoitt is the Chief Commercial Officer of Dova Pharmaceuticals Inc and owns about 9,970 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $279,559. Jason Hoitt is also the Chief Commercial Officer of Provention Bio Inc and owns about 0 shares of Provention Bio Inc (PRVB) stock worth over $0. Details can be seen in Jason Hoitt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Hoitt has not made any transactions after 2023-02-10 and currently still holds the listed stock(s).
Transaction Summary of Jason Hoitt
Jason Hoitt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Hoitt owns 2 companies in total, including Provention Bio Inc (PRVB) , and Dova Pharmaceuticals Inc (DOVA) .
Click here to see the complete history of Jason Hoitt’s form 4 insider trades.
Insider Ownership Summary of Jason Hoitt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRVB | Provention Bio Inc | 2023-02-10 | Chief Commercial Officer |
| DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | Chief Commercial Officer |
Jason Hoitt Latest Holdings Summary
Jason Hoitt currently owns a total of 2 stocks. Among these stocks, Jason Hoitt owns 9,970 shares of Dova Pharmaceuticals Inc (DOVA) as of September 30, 2019, with a value of $279,559 and a weighting of 100%. Jason Hoitt also owns 0 shares of Provention Bio Inc (PRVB) as of February 10, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Jason Hoitt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DOVA | Dova Pharmaceuticals Inc | 2019-09-30 | 9,970 | 28.04 | 279,559 |
| PRVB | Provention Bio Inc | 2023-02-10 | 0 | 24.98 | 0 |
Holding Weightings of Jason Hoitt
Jason Hoitt Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Hoitt has made a total of 3 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Dova Pharmaceuticals Inc is the sale of 2,387 shares on September 30, 2019, which brought Jason Hoitt around $66,836.
According to the SEC Form 4 filings, Jason Hoitt has made a total of 2 transactions in Provention Bio Inc (PRVB) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Provention Bio Inc is the sale of 4,500 shares on February 10, 2023, which brought Jason Hoitt around $45,000.
Insider Trading History of Jason Hoitt
- 1
Jason Hoitt Trading Performance
GuruFocus tracks the stock performance after each of Jason Hoitt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Hoitt is 172%. GuruFocus also compares Jason Hoitt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Hoitt within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason Hoitt's insider trading performs compared to the benchmark.
Performance of Jason Hoitt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 89.6 | | | | | |
| Relative Return to S&P 500(%) | 70.29 | | | | | |
Jason Hoitt Ownership Network
Jason Hoitt Owned Company Details
What does Provention Bio Inc do?
Who are the key executives at Provention Bio Inc?
Jason Hoitt is the Chief Commercial Officer of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & President and CEO Ashleigh Palmer , and director & 10 percent owner & Chief Scientific Officer Francisco Leon .
Provention Bio Inc (PRVB) Insider Trades Summary
Over the past 18 months, Jason Hoitt made 1 insider transaction in Provention Bio Inc (PRVB) with a net sale of 4,500. Other recent insider transactions involving Provention Bio Inc (PRVB) include a net sale of 299,617 shares made by Francisco Leon , a net sale of 5,190,549 shares made by Sessa Capital (master), L.p. , and a net sale of 100,000 shares made by Ashleigh Palmer .
In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc (PRVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,594,666 shares of Provention Bio Inc (PRVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,594,666 shares.
Provention Bio Inc (PRVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Provention Bio Inc Insider Transactions
Jason Hoitt Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Hoitt. You might contact Jason Hoitt via mailing address: C/o Dova Pharmaceuticals, Inc., 240 Leigh Farm Road, Suite 245, Durham Nc 27707.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
